Lanean...
Handling interoccasion variability in model‐based dose individualization using therapeutic drug monitoring data
AIMS: This study aims to assess approaches to handle interoccasion variability (IOV) in a model‐based therapeutic drug monitoring (TDM) context, using a population pharmacokinetic model of coagulation factor VIII as example. METHODS: We assessed 5 model‐based TDM approaches: empirical Bayes estimate...
Gorde:
| Argitaratua izan da: | Br J Clin Pharmacol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533430/ https://ncbi.nlm.nih.gov/pubmed/30767254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13901 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|